Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?

Terapevticheskii Arkhiv

Volumn 78, Issue 8, 2006, Pages 30-38

  Blagova, O V ^a   Nedostup, A V ^a  

^a NONE

Author keywords

Beta blockers; Diltiazem; Fibrillation tachyarrhythmia; Interval histogram RR; Rhythm structure; Verapamil

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; METOPROLOL; VERAPAMIL;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART RATE; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ATENOLOL; ATRIOVENTRICULAR NODE; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION; VERAPAMIL;

EID: 33749024427     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur. Heart J. 2001; 22: 1852-1923.
2. Farshi R., Kistner D., Sarma J. S. et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J. Am. Coll. Cardiol. 1999; 33: 304-310.
3. Lanas F., Salvatisi R., Castillo G. et al. Comparison between digoxin and atenolol in chronic atrial fibrillation. Rev. Med. Chil. 1995; 123: 1252-1262.
4. Lewis R. V., Lakhani M., Moreland T. A. et al. A comparison of verapamil and digoxin in the treatment of atrial fibrillation. Eur. Heart J. 1987; 8: 148-153.
5. Lewis R. V., McMurray J., McDevitt D. G. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. J. Cardiovasc. Pharmacol. 1989; 13: 1-6.
6. Segal J. B., McNamara R. L., Miller M. R. et al. The evidence regarding the drugs used for ventricular rate control. J. Fam. Pract. 2000; 49: 47-59.
7. Ang E. L., Chan W. L., Cleland J. G. et al. Placebo-controlled trial of xamotrol versus digoxin in chronic atrial fibrillation. Br. Heart J. 1990; 64: 256-260.
8. Heywood J. T. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure. Can. J. Cardiol. 1995; 11: 823-826.
9. Pomfret S. M., Beasley C. R., Challenor V. et al. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation. Clin. Sci. 1988; 74: 351-357.
10. Vitale P., Auriccio A., De Stefano R. et al. Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study. Cardiologia 1989; 34: 73-81.
11. Lundström T., Rydén L. Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil. J. Am. Coll. Cardiol. 1990; 16: 86-90.
12. Billette J., Nadeau R. A., Roberge F. Relation between the minimum RR interval during atrial fibrillation and the functional refractory period of the AV junction. Cardiovasc. Res. 1974; 8: 347-351.
13. Rowland E., Curry P., Fox K. et al. Relation between atrioventricular pathways and ventricular response during atrial fibrillation and flutter. Br. Heart J. 1981; 45: 83-87.
14. Toivonen L., Kadish A., Kou W. et al. Determinants of the ventricular rate during atrial fibrillation. J. Am. Coll. Cardiol. 1990; 16: 1194-2000.
15. van den Berg M. P., Haaksma J., Brouwer J. et al. Heart rate variability in patients with atrial fibrillation is related to vagal tone. Circulation 1997; 96: 1209-1216.
16. van den Berg M. P., de Langen C. D., Crijns H. J. et al. Effect of metoprolol on atrial fibrillatory rate, atrioventricular nodal concealed conduction, and ventricular response during atrial fibrillation in pigs. J. Cardiovasc. Pharmacol. 1994; 23 (5): 846-851.
17. Fiyiki A., Tani M., Mizumaki K. et al. Quantification of human concealed atrioventricular nodal conduction: relation to ventricular response during atrial fibrillation. Am. Heart J. 1990; 120 (3): 598-603.
18. Tieleman R. G., De Langen C., van Gelder I. C. et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997; 95 (7): 1945-1953.
19. Meurling C. J., Ingemansson M. P., Roijer A. et al. Attenuation of electrical remodeling in chronic atrial fibrillation following oral treatment with verapamil. Europace 1999; 1: 234-241.
20. Ramanna H., Elvan A., Wittkampf F. H. et al. Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation. J. Am. Coll. Cardiol. 2001; 37: 1403-1407.
21. Manios E. G., Mavrakis H. E., Kanoupakis E. M. et al. Effects of amiodarone and diltiazem on persistent atrial fibrillation and recurrence rate: a randomized controlled study. Cardiovasc. Drugs Ther. 2003; 17 (1): 31-39.
22. van den Berg M. P., Krijns H. J., Haaksma J. et al. Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation. Clin. Sci. 1994; 86: 531-535.
23. Klein G. J., Twum-Barima Y., Gulamhusein S. et al. Verapamil in chronic atrial fibrillation: variable patterns of response in ventricular rate. Clin. Cardiol. 1984; 7: 474-483.
24. Neuss H., Golling F. R., Schlepper M. et al. Regularization of ventricular intervals in atrial fibrillation -electrophysiologic findings on the underlying mechanism. Z. Kardiol. 1984; 73: 106-112.
25. Theisen K., Haufe M., Peters J. et al. Effect of calcium antagonist diltiazem on atrioventricular conduction in chronic atrial fibrillation. Am. J. Cardiol. 1985; 55: 98-102.
26. Fujici F., Mizumaki K., Tani M. Effects of diltiazem on concealed atrioventricular nodal conducton in relation to ventricular response during atrial fibrillation in anesthetized dogs. Am. Heart J. 1993; 125: 1284.
27. Talajic M., Nayebpour M., Jing W, et al. Frequency-dependent effects of diltiazem on the experimental atrial fibrillation. Circulation 1989; 30: 380-389.